ANN REED: Open Payments
NPI 1649341256 · DIAMONDHEAD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 19 payments from 7 companies in 2025. Trend: 2023 $576 · 2024 $535 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $82 |
| Amgen Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| ABBVIE INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: MOUNJARO, CAPLYTA, EVENITY, BREZTRI, UBRELVY, The Cologuard Plus Collection Kit, FARXIGA, Cologuard Collection Kit.
Industry payments across MS — which companies pay providers there.
